Market Performance - On April 23, A-shares showed mixed performance, with the Shanghai Composite Index down by 0.1% to 3296.36 points, while the Shenzhen Component Index rose by 0.67% to 9935.8 points, and the ChiNext Index increased by 1.07% to 1949.16 points [1] Fund Manager Changes - In the past 30 days (March 24 to April 23), a total of 594 fund managers have left their positions, with 32 announcements made on April 23 alone. The reasons for these changes include work transitions for 4 managers across 7 funds and 3 managers across 25 funds [3][4] Fund Manager Profiles - Fund manager Yan Yifan from Chuangjin Hexin has managed funds totaling 28.676 billion yuan, with the highest return of 47.27% on the Chuangjin Hexin Xinqi Mixed A fund over 5 years and 35 days [4] - Zhao Jianzhong from Zhongyin Fund has managed funds totaling 3.976 billion yuan, achieving a return of 92.05% on the Zhongyin Shanghai Gold ETF over 4 years and 239 days [5] Fund Company Research Activity - In the last month, Boshi Fund conducted the most company research, engaging with 116 listed companies, followed by Jiashi Fund with 96, and Fuguo Fund with 90 [7][8] - The most researched industry was consumer electronics, with 429 instances, followed by chemical products with 392 [8] Recent Fund Research Focus - The most focused stock in the last month was Luxshare Precision, with 141 fund management companies participating in its research, followed by Lanke Technology and Lens Technology with 98 and 93 respectively [8][10] - In the past week (April 16 to April 23), the most researched company was Baiya Co., Ltd., with 70 fund institutions involved [9][10]

在4月以来的市场巨震中，中央汇金首次明确其类"平准基金"定位，大举增持ETF，极大地提振了市场信心。事实上，根据最新披露的基金 2025年一季报，今年一季度，中央汇金已悄然增持了多只沪深300ETF。 中央汇金持续增持ETF 华泰柏瑞沪深300ETF发布的2025年一季报显示，今年初"机构2"持有该ETF 266.21亿份。根据该ETF的2024年年报，截至去年底，中央汇 金资产管理有限责任公司持有该ETF266.21亿份。 上述数字表明，"机构2"即为中央汇金资产管理有限责任公司。今年一季度，"机构2"增持该ETF 3.63亿份，如下图所示： | 资 | | 持有基金 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 右 | | 份额比例 | | | | | | | 开 | 序号 | 达到或者 | 期初 份额 | 申购 份额 | 应回 份额 | 持有份额 | 份额占比 (%) | | | | 超过 20% | | | | | | | | | 的时间区 | | | | | | | | | 日 | | | | | | | 机 | 1 ...

Core Viewpoint - The recent fund quarterly reports reveal significant increases in holdings of major ETFs by the "national team," particularly by the Central Huijin Investment Ltd, which has injected over 200 billion yuan into several ETFs, indicating a strong commitment to stabilizing the capital market [2][12]. Group 1: National Team's ETF Purchases - The Central Huijin Investment Ltd has notably increased its holdings in several large-scale ETFs, including the Huatai-PB CSI 300 ETF, which now exceeds 300 billion yuan in size, with an increase of 363 million units in Q1 2024 [4][5]. - Other ETFs such as the Huaxia CSI 300 ETF, Harvest CSI 300 ETF, and E Fund CSI 300 ETF also saw significant increases in holdings, with respective increases of 157 million, 117 million, and 502 million units [6]. - By the end of 2024, the total amount held by the Central Huijin Investment Ltd in ETFs surpassed 1 trillion yuan, reflecting its role as a stabilizing force in the market [12]. Group 2: Market Impact and Future Outlook - The "national team" has been actively involved in the stock ETF market since early 2023, with a notable public announcement of continued purchases aimed at maintaining market stability [8][10]. - In April 2024, the net inflow into stock ETFs reached a historical high, with a total of 1,117.8 billion yuan, largely attributed to the "national team" investments, providing crucial support for the A-share market [13]. - Fund managers express optimism about A-share investment opportunities, highlighting potential structural opportunities and the importance of policy continuity in the second quarter of 2024 [15].

Core Viewpoint - Anbiping's 2024 annual report indicates a slight decline in revenue but significant improvements in business quality and structure, with a focus on digital pathology solutions integrating AI technology [1][2]. Group 1: Financial Performance - In 2023, Anbiping achieved a revenue of 471 million yuan, a year-on-year decrease of 5.33%, primarily due to a 31.28% drop in sales from externally sourced products [1]. - The revenue from self-developed products continues to increase, indicating a shift in the company's revenue structure [1]. Group 2: Business Development - Anbiping has established four main business areas: tumor screening, tumor diagnosis, digital pathology, and pathology services, with a strong emphasis on tumor screening and precision diagnosis [2]. - The company reported over 20% year-on-year growth in revenue from immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) products, with digital pathology product revenue increasing by 80% [2]. Group 3: Research and Innovation - Anbiping invested 60.06 million yuan in R&D, accounting for 12.76% of its revenue, focusing on digital pathology and tumor companion diagnostic reagent development [2]. - The company has upgraded its digital slice scanning system to meet diverse needs from primary to tertiary hospitals, and is advancing the registration of AI-assisted cervical cancer screening products [2]. Group 4: Market Strategy - In 2024, Anbiping's digital technology has been commercialized at the grassroots medical level, with a 90% year-on-year increase in co-construction business revenue and partnerships with 60 hospitals [3]. - The company aims to address the shortage of pathologists in grassroots settings by transforming the diagnostic model from external to internal, enhancing clinical diagnostic capabilities [3]. Group 5: AI and Future Prospects - The AI pathology sector is expected to grow significantly, particularly in cancer diagnosis, driven by advancements in digital imaging and AI algorithms [4]. - Anbiping has attracted attention from 264 institutions for its AI and overseas business strategies, focusing on enhancing internal processes and product capabilities through AI [4].

Group 1 - The resignation of Cheng Fei, Vice President of Guosen Securities, has been announced alongside the company's 2024 annual report, with Fang Qiang appointed as the director of the asset management subsidiary [1] - Guosen Securities' asset management business revenue saw a significant year-on-year increase of 60.55%, making it one of the fastest-growing segments alongside investment and trading [1] - Cheng Fei is set to join Dongfang Hong Asset Management, a leading institution in the brokerage asset management industry, following the departure of its former general manager [1] Group 2 - The ETF market has surpassed 4 trillion yuan in size, with net inflows exceeding 300 billion yuan within the month, indicating strong investor interest in index-based investments [2][3] - Major broad-based ETFs such as the CSI 300 ETF and the CSI 500 ETF have attracted significant capital, reflecting increased confidence in large-cap blue-chip and growth stocks [2][3] - Commodity ETFs and industry-themed ETFs have also shown strong inflows, highlighting market focus on specific assets and sectors [2][3] Group 3 - Public fund issuance has accelerated, surpassing 30 billion yuan in April, with over 70% being equity products, indicating a growing preference for equity assets [4] - Newly issued index funds dominate the market, accounting for nearly 90% of the number and scale of new equity products, suggesting a shift towards passive investment strategies [4] - The increase in equity fund issuance reflects a recovery in market risk appetite, which may positively impact overall market sentiment [4] Group 4 - Over 70 billion yuan in net inflows were recorded for broad-based ETFs, with the total market size exceeding 4 trillion yuan, indicating strong demand for large-cap stocks [5] - The CSI 300 ETF's total size has returned to over 1 trillion yuan, showcasing investor preference for core assets [5] - The market is expected to focus more on company performance and growth potential as fundamental factors become the primary pricing determinants [5]

随着嘉实上证科创板工业机械ETF于今日成立，嘉实基金在科创板领域细分赛道的布局，已经达到了4 只，另外三只分别是嘉实上证科创板新一代信息技术、嘉实上证科创板芯片ETF及联接、嘉实上证科创 板生物医药ETF及联接。 无论是数量或是规模，均已成为公募基金行业里布局科创板细分赛道的领头羊。除此之外，嘉实还在科 创宽基上做了充分布局，如嘉实上证科创板综合ETF、嘉实上证科创板50指数增强，以及近期首批上报 的嘉实上证科创板综合增强ETF。 时代在变，科技的主题也在变。 从威尼斯玻璃匠的熔炉点燃文艺复兴，到瓦特蒸汽机叩开工业革命；从贝尔实验室的晶体管开启了信息 时代的新篇章，到AI大模型重构知识边疆——人类文明的每一次升维，都刻着科技进化的烙印。 全球科技博弈进入深水区。当纳斯达克哺育出一批科技公司时，我国也搭建了自己的"硬科技摇篮"—— 科创板。 2018年诞生的科创板犹如一把利剑，直指新一代信息技术、高端装备、新材料、生物医药等战略高地， 为中国的"卡脖子"技术突围提供资本支持，在百年未有之大变局中铺就一条从"中国制造"到"中国智 造"的星辰大海之路。 在这片孕育科技创新的沃土上，嘉实基金作为中国公募基金行业的一员 ...

4月16日，瑞普生物连续4个交易日下跌，区间累计跌幅-8.94%。瑞普生物股份有限公司,作为我国动物保健品行业的领军企业,中国A股市场上专注于兽药领 域的上市公司,秉承"前瞻、创新、正直、分享"的企业理念,为动物健康、动物源性食品安全、人畜共患病的解决贡献着力量。 简历显示，吴越先生:中国国籍,硕士学历,2013年6月加入嘉实基金管理有限公司研究部任研究员一职,先后负责A股食品饮料、轻工等行业的研究工作。2020 年12月9日任嘉实农业产业股票型证券投资基金基金经理。2020年12月9日任嘉实消费精选股票型证券投资基金基金经理。现任嘉实消费精选研究副总监。 2021年10月22日担任嘉实新起航灵活配置混合型证券投资基金基金经理。2022年1月6日至今任嘉实内需精选混合型证券投资基金基金经理。2024年12月16日 起担任嘉实新收益灵活配置混合型证券投资基金基金经理。2024年12月24日担任嘉实瑞虹三年定期开放混合型证券投资基金基金经理。 | ○ 基金经理:吴越 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | ...

4月8日，A股主要指数企稳回升，市场交投活跃，多只代表性宽基ETF成交急剧放量。 券商中国记者注意到，沪深300、中证500等宽基ETF集体发力，纷纷占据ETF成交榜单前列。其中，有着 市场"巨无霸"之称的华泰柏瑞沪深300ETF表现突出，连续两个交易日成交额突破200亿元，成为市场资金 追逐的焦点。此外，南方中证500ETF、易方达沪深300ETF等多只宽基ETF的单日成交额也纷纷突破百亿 元。 业内人士指出，ETF成交额的变化是观察市场情绪和资金动向的重要"风向标"。在市场波动加剧、走势不 明朗时，投资者往往更倾向于选择兼具流动性和广谱性的宽基ETF产品，以灵活应对潜在的不确定性。当 前ETF成交放量，体现出资金积极布局的意愿，这或许意味着市场的风险偏好正迎来阶段性修复。 多只宽基ETF单日成交额破百亿元 4月8日，A股主要指数震荡上行，市场情绪明显修复。券商中国记者注意到，市场交投活跃，宽基ETF成 为成交榜前列的"主力军"。多只宽基ETF单日成交额突破百亿元，呈现出鲜明的结构性放量特征。 从成交数据来看，华泰柏瑞沪深300ETF以216.69亿元的单日成交额继续位居全市场ETF成交榜首，虽然 较4月7 ...

Report Summary 1. Market Overview - The Shanghai Composite Index rose 1.58% to close at 3145.55 points, the Shenzhen Component Index rose 0.64% to close at 9424.68 points, and the ChiNext Index rose 1.83% to close at 1840.31 points. The total trading volume of A-shares in the two markets was 1.6536 trillion yuan. The top-performing sectors were agriculture, forestry, animal husbandry and fishery (7.81%), commerce and retail (3.44%), and food and beverages (3.37%), while the worst-performing sectors were electronics (-1.69%), automobiles (-1.63%), and communications (-0.93%) [2][7]. 2. Stock ETFs - The top trading volume stock ETFs were Huatai-PineBridge CSI 300 ETF (up 0.95% with a discount rate of 1.45%), Southern CSI 500 ETF (up 0.62% with a discount rate of 0.56%), and E Fund CSI 300 ETF (up 2.26% with a discount rate of 1.41%) [3][8]. 3. Bond ETFs - The top trading volume bond ETFs were Penghua ChinaBond 30-Year Treasury Bond ETF (down 0.70% with a discount rate of -0.57%), Bosera CSI Convertible Bond and Exchangeable Bond ETF (up 1.06% with a discount rate of 0.61%), and Fullgoal ChinaBond 7-10 Year Policy Financial Bond ETF (down 0.40% with a discount rate of -0.19%) [4][10]. 4. Gold ETFs - Gold AU9999 rose 0.49% and Shanghai Gold rose 0.30%. The top trading volume gold ETFs were HuaAn Gold ETF (up 0.70% with a discount rate of 0.93%), E Fund Gold ETF (up 0.54% with a discount rate of 0.83%), and Bosera Gold ETF (up 0.61% with a discount rate of 0.90%) [13]. 5. Commodity Futures ETFs - The top trading volume commodity futures ETFs were ChinaAMC Feed Soybean Meal Futures ETF (up 3.70% with a discount rate of 2.62%), Dacheng Nonferrous Metals Futures ETF (up 0.63% with a discount rate of -1.45%), and CCB ESG Zhengzhou Commodity Exchange Energy and Chemical Futures ETF (up 1.20% with a discount rate of -3.12%) [14]. 6. Cross-Border ETFs - The previous trading day, the Dow Jones Industrial Average fell 0.91%, the Nasdaq Composite rose 0.10%, the S&P 500 fell 0.23%, and the German DAX fell 4.13%. Today, the Hang Seng Index rose 1.51% and the Hang Seng China Enterprises Index rose 2.31%. The top trading volume cross-border ETFs were ChinaAMC Hang Seng Tech ETF (down 4.39% with a discount rate of 4.63%), Huatai-PineBridge CSOP Hang Seng Tech ETF (down 3.42% with a discount rate of 5.17%), and E Fund CSI Overseas Internet ETF (down 3.13% with a discount rate of -12.18%) [16]. 7. Money Market ETFs - The top trading volume money market ETFs were Silver HuaRiLi ETF, HuaBao TianYi ETF, and CCB TianYi Money Market ETF [18].

4月7日 1 7 : 0 0 ，富时A5 0中国指数期货重开后走高，一度涨超3%，截至北京时间2 0 : 4 7，涨 幅为2 . 3 4%。该指数1 6 : 3 0收盘下跌8 . 4 5%。 | 富时中国A50期货 | | | | | W | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CN.SG | | | | | | | | | | | | | 昨结 | 11924 | 总手 | | | | 12203 | | | | 8.03万 | | | 11945 | | 现手 | | | +279 | +2.34% 十字 | | | | 3 | | | 估结算 | | 基 差 | | | 结算价 | | | | | 0.00 | | | EK | | FK | | | 分时 | 五日 글 K | | | 申念 | | | | | | 3.04% = | 12204 | | 12287.00 | | | | | | | | | | | | | | | | | | | 4 | | | | ...